Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A
Journal of Virology · 2023
DOI: 10.1128/jvi.00700-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Nan Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Xuzhou Medical University , Xuzhou, China. Hauptthemen laut MEDLINE: Adenovirus E1A Proteins, Adenoviruses, Human, Apoptosis Regulatory Proteins, Virus Replication. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Key Research and Development Program of China, MOST | National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Human adenovirus (HAdV) is ubiquitous in the human population, constituting a significant burden of global respiratory diseases. Children and individuals with low immunity are at risk of developing severe infections without approved antiviral treatment for HAdV. Our study demonstrated that TRIM35 inhibited HAdV-C5 early gene transcription, early protein expression, genome replication, and infectious virus progeny production. Furthermore, TRIM35 was found to inhibit HAdV replication by attenuating E1A expression. Mechanistically, TRIM35 interacts with and degrades E1A by promoting its K48-linked ubiquitination. Additionally, K253 and K285 are the key sites necessary for TRIM35 degradation. Moreover, an oncolytic adenovirus carrying shTRIM35 was constructed and observed to exhibit improved oncolysis in vivo , providing new ideas for clinical tumor treatment. Our results expand the broad antiviral activity of TRIM35 and mechanically support its application as a HAdV replication inhibitor. IMPORTANCE E1A is an essential human adenovirus (HAdV) protein responsible for the early replication of adenovirus while interacting with multiple host proteins. Understanding the interaction between HAdV E1A and TRIM35 helps identify effective antiviral therapeutic targets. The viral E1A protein is a crucial activator and regulator of viral transcription during the early infection stages. We first reported that TRIM35 interacts with E1A to resist adenovirus infection. Our study demonstrated that TRIM35 targets E1A to resist adenovirus, indicating the applicability of targeting virus-dependent host factors as a suitable antiviral strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xuzhou Medical University , Xuzhou, China.
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University , Xuzhou, China.
- Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.
ORCID-Profile: Gang Wang
Förderung
- MOST | National Key Research and Development Program of China
- MOST | National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- JPDE | Natural Science Research of Jiangsu Higher Education Institutions of China
- Xuzhou Medical University
Zitieren
APA
Sun, N., Zhang, J., Zhang, C., Xie, T., Zhang, Z., Wang, X., Li, W., Zhang, Y., Chen, Z., Zheng, J., Fang, L., & Wang, G. (2023). Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A. Journal of Virology. https://doi.org/10.1128/jvi.00700-23
Vancouver
Sun N, Zhang J, Zhang C, Xie T, Zhang Z, Wang X, et al. Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A. Journal of Virology. 2023. doi:10.1128/jvi.00700-23
BibTeX
@article{Sun2023,
author = {Sun, Nan and Zhang, Jikai and Zhang, Chen and Xie, Tan and Zhang, Zeyu and Wang, Xueyan and Li, Wanjing and Zhang, Yi and Chen, Zhaokai and Zheng, Junnian and Fang, Lin and Wang, Gang},
title = {Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.00700-23}
}
EUVIMED